Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-019398
Filing Date
2019-05-15
Accepted
2019-05-15 16:07:02
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opgn-10q_20190331.htm 10-Q 1445730
2 EX-31.1 opgn-ex311_7.htm EX-31.1 15511
3 EX-31.2 opgn-ex312_6.htm EX-31.2 15555
4 EX-32.1 opgn-ex321_8.htm EX-32.1 13256
  Complete submission text file 0001564590-19-019398.txt   6855653

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT opgn-20190331.xml EX-101.INS 1485930
6 XBRL TAXONOMY EXTENSION SCHEMA opgn-20190331.xsd EX-101.SCH 63612
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opgn-20190331_cal.xml EX-101.CAL 66946
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opgn-20190331_def.xml EX-101.DEF 215092
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE opgn-20190331_lab.xml EX-101.LAB 481501
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opgn-20190331_pre.xml EX-101.PRE 371411
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 19828081
SIC: 8071 Services-Medical Laboratories